BIOTU

Biotech Acquisition Company [BIOTU] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BIOTU Stock Summary

In the News

08:00 28 Mar 2024 BIOTU

Biotech Acquisition Company Announces Separate Trading of its Class A Ordinary Shares and Warrants Commencing March 18, 2021

NEW YORK, March 15, 2021 /PRNewswire/ -- Biotech Acquisition Company (NASDAQ: BIOTU) (the "Company") announced that, commencing March 18, 2021, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares ("Class A Ordinary Shares") and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

02:59 28 Mar 2024 BIOTU

Biotech Acquisition Company Announces Closing of $230,000,000 Initial Public Offering

New York, NY, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”) announced today that it has closed its initial public offering of 23,000,000 units, including 3,000,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $230,000,000.

BIOTU Financial details

Company Rating
-
Market Cap
0
Income
13.24M
Revenue
0
Book val./share
-0.46
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0.01
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
0.03
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.11
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-86.24%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
10%
ROE
23%
ROC
-0.01%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.73-11.1146
52W High
-7.82%
52W Low
+26.75%
RSI
-
Rel Volume
1.68
Avg Volume
797
Volume
1.34K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-7.65%
-
-
-
-
Beta
-
-
-
Volatility
0.36%, 0.36%
Prev Close
0%
Price
10.14
Change
-0.2%

BIOTU Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2020-12-31 2021-12-31
2.02K2.02K
Revenue per share
00
Net income per share
0-0.42
Operating cash flow per share
0-0.05
Free cash flow per share
0-0.05
Cash per share
00
Book value per share
00
Tangible book value per share
00
Share holders equity per share
00
Interest debt per share
00.18
Market cap
278.88M282.9M
Enterprise value
278.88M282.9M
P/E ratio
0-23.27
Price to sales ratio
00
POCF ratio
0-193.08
PFCF ratio
0-193.08
P/B Ratio
13.94K-10.41M
PTB ratio
13.94K-10.41M
EV to sales
00
Enterprise value over EBITDA
0-41.21
EV to operating cash flow
0-193.08
EV to free cash flow
0-193.08
Earnings yield
0-0.04
Free cash flow yield
0-0.01
Debt to equity
3.480
Debt to assets
0.780
Net debt to EBITDA
00
Current ratio
00.95
Interest coverage
0-0.3
Income quality
00.21
Dividend Yield
00
Payout ratio
00
Sales general and administrative to revenue
00
Research and developement to revenue
00
Intangibles to total assets
00
Capex to operating cash flow
00
Capex to revenue
00
Capex to depreciation
00
Stock based compensation to revenue
00
Graham number
00
ROIC
0102.36K
Return on tangible assets
0-52.79K
Graham Net
00
Working capital
-69.5K-0.01
Tangible asset value
20K202.85
Net current asset value
-69.5K-27.17
Invested capital
3.480
Average receivables
00
Average payables
00
Average inventory
00
Days sales outstanding
00
Days payables outstanding
00
Days of inventory on hand
00
Receivables turnover
00
Payables turnover
00
Inventory turnover
00
ROE
0447.52K
Capex per share
00

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
0.1-0.50.810.70.1
Operating cash flow per share
-0.02-0.01-0.02-0.010
Free cash flow per share
-0.02-0.01-0.02-0.010
Cash per share
0.0100.0200
Book value per share
7.31-0.95-3.91-0.46-0.46
Tangible book value per share
7.317.0636.097.547.59
Share holders equity per share
7.31-0.95-3.91-0.46-0.46
Interest debt per share
00.240-0.37-0.05
Market cap
280.03M282.9M56.7M284.63M285.2M
Enterprise value
279.62M282.81M56.59M284.62M285.19M
P/E ratio
23.8-4.973.033.5525.74
Price to sales ratio
00000
POCF ratio
-523.66-909.68-554.04-1.18K-1.99K
PFCF ratio
-523.66-909.68-554.04-1.18K-1.99K
P/B Ratio
1.33-10.41-2.52-21.29-21.74
PTB ratio
1.33-10.41-2.52-21.29-21.74
EV to sales
00000
Enterprise value over EBITDA
95.05-38.82-29.8330.33226.08
EV to operating cash flow
-522.91-909.38-553.02-1.18K-1.99K
EV to free cash flow
-522.91-909.38-553.02-1.18K-1.99K
Earnings yield
0.01-0.050.080.070.01
Free cash flow yield
00000
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
-0.140.010.050-0.01
Current ratio
1.880.950.140.040.03
Interest coverage
0-0.0500.120.16
Income quality
-0.180.04-0.02-0.02-0.11
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
4.13.258.462.70.99
ROIC
00.020.080.20.04
Return on tangible assets
0.01-0.060.020.090.01
Graham Net
-0.7-0.95-3.95-0.47-0.46
Working capital
315.61K-14.35K-1.91M-3.18M-3.42M
Tangible asset value
210.14M202.85M207.53M216.91M218.17M
Net current asset value
-19.88M-27.17M-22.51M-13.37M-13.12M
Invested capital
00000
Average receivables
00000
Average payables
178.84K178.84K000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
51.110000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
1.760000
Inventory turnover
00000
ROE
0.010.52-0.21-1.5-0.21
Capex per share
00000

BIOTU Frequently Asked Questions

What is Biotech Acquisition Company stock symbol ?

Biotech Acquisition Company is a US stock , located in New york of Ny and trading under the symbol BIOTU

What is Biotech Acquisition Company stock quote today ?

Biotech Acquisition Company stock price is $10.14 today.

Is Biotech Acquisition Company stock public?

Yes, Biotech Acquisition Company is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap